Nuzenio

Disease Trial Data

Disease Trial Data news intelligence with latest source-attributed stories, timeline, related explainers, connected entities, source diversity, and FAQ.

topic 9 latest news signals 8 publisher sources 100/100 entity strength

Latest news

DPP1 Inhibition in Bronchiectasis: Mechanism and Pivotal Trial Data - hcplive.comhcplive.com · Fri, 07 Aug 2026 13:06:06 GMTVistagen’s Fasedienol Phase 2 Data Due August 2026 for Social Anxiety - The Clinical Trial VanguardThe Clinical Trial Vanguard · Fri, 07 Aug 2026 06:39:00 GMTInterim Trial Results and Preclinical Data Highlight Potential of ABS-201 in Androgenetic Alopecia - Dermatology TimesDermatology Times · Thu, 06 Aug 2026 18:09:33 GMTAscendis Reports 78-Week Data From COACH Trial for Achondroplasia - hcplive.comhcplive.com · Thu, 06 Aug 2026 13:52:13 GMTBioVie’s stock sinks 50% as company uses composite endpoint to make case for Parkinson’s program - fiercebiotech.comfiercebiotech.com · Thu, 06 Aug 2026 13:40:09 GMTPrilenia shares HD trial data with CHDI to help future research - HDBuzzHDBuzz · Thu, 06 Aug 2026 13:00:00 GMTTranslating PFS Data for Patients: How Community Oncologists Communicate Trial Outcomes in RRFL - The American Journal of Managed CareThe American Journal of Managed Care · Thu, 06 Aug 2026 12:24:30 GMTBioVie Announces Topline Results of Phase 2 SUNRISE-PD Trial of Bezisterim in Early Parkinson’s Disease - The Manila TimesThe Manila Times · Thu, 06 Aug 2026 11:40:50 GMT

Timeline

Fri, 07 Aug 2026 13:06:06 GMTDPP1 Inhibition in Bronchiectasis: Mechanism and Pivotal Trial Data - hcplive.com
Fri, 07 Aug 2026 06:39:00 GMTVistagen’s Fasedienol Phase 2 Data Due August 2026 for Social Anxiety - The Clinical Trial Vanguard
Thu, 06 Aug 2026 18:09:33 GMTInterim Trial Results and Preclinical Data Highlight Potential of ABS-201 in Androgenetic Alopecia - Dermatology Times
Thu, 06 Aug 2026 13:52:13 GMTAscendis Reports 78-Week Data From COACH Trial for Achondroplasia - hcplive.com
Thu, 06 Aug 2026 13:40:09 GMTBioVie’s stock sinks 50% as company uses composite endpoint to make case for Parkinson’s program - fiercebiotech.com
Thu, 06 Aug 2026 13:00:00 GMTPrilenia shares HD trial data with CHDI to help future research - HDBuzz

FAQ

What does this page track?

Latest RSS headlines, source names, timestamps, related explainers, connected entities, and timeline signals for Disease Trial Data.

Why might this page be noindex?

Nuzenio only indexes entity pages after enough useful source-attributed coverage and source diversity exists.

Where should readers verify facts?

Open the original publisher links from each story for full reporting, quotes, figures, images, corrections, and updates.

Source diversity

8 distinct publisher/source names are currently connected to this entity page.